M&T Bank’s Lifecore Biomedical LFCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-15,240
Closed -$219K 1916
2015
Q2
$219K Sell
15,240
-2
-0% -$29 ﹤0.01% 1716
2015
Q1
$213K Sell
15,242
-325
-2% -$4.49K ﹤0.01% 1715
2014
Q4
$215K Sell
15,567
-8,246
-35% -$107K ﹤0.01% 1711
2014
Q3
$292K Buy
+23,813
New +$297K ﹤0.01% 1590

Other funds holding LFCR

M&T Bank's LFCR Position: Q3 2015 in Review

M&T Bank sold out of Lifecore Biomedical (LFCR) in Q3 2015, closing a stake of 15,240 shares — an estimated $219K sold.

M&T Bank first reported a position in LFCR in Q3 2014 and held it in 4 quarters. The position peaked at $292K in Q3 2014. 111 funds tracked by Wall St. Rank hold LFCR as of Q3 2015.

  • M&T Bank reported no remaining Lifecore Biomedical position as of Q3 2015 after selling out during the quarter.
  • M&T Bank sold 15,240 Lifecore Biomedical shares in Q3 2015, an estimated $219K.
  • M&T Bank first reported a position in Lifecore Biomedical in Q3 2014 and held it in 4 quarters.
  • M&T Bank's Lifecore Biomedical position peaked at $292K in Q3 2014.
  • 111 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2015.

Based on M&T Bank's 13F filing for Q3 2015, filed 13 Nov 2015.